Yu, Q., Wan, D., Fu, R., Li, F., & Zhang, Y. (2023). Overexpression of TPL2 may be a predictor of good prognosis in patients with breast invasive ductal carcinoma. Nature Portfolio.
Cita Chicago Style (17a ed.)Yu, Qin, Dan Wan, Rong Fu, Feng Li, y Yutao Zhang. Overexpression of TPL2 May Be a Predictor of Good Prognosis in Patients with Breast Invasive Ductal Carcinoma. Nature Portfolio, 2023.
Cita MLA (9a ed.)Yu, Qin, et al. Overexpression of TPL2 May Be a Predictor of Good Prognosis in Patients with Breast Invasive Ductal Carcinoma. Nature Portfolio, 2023.
Precaución: Estas citas no son 100% exactas.